Author - prodiathecro

PRODIA CLINICAL LAB RECEIVED THE CAP ACCREDITATION

Prodia Clinical Laboratory – which is the largest and the best independent laboratory in Indonesia achieved The College of American Pathologist (CAP) accreditation in July 2012; making it the first and the only one Clinical Laboratory in Indonesia and together with 7000’s reputable clinical laboratory worldwide to hold this accreditation. The CAP laboratory accreditation is an internationally recognized program that is accepted as the gold standard for quality to improve patient safety. Prodia Clinical Laboratory provides a wide range of [...]

Read more...

Quintiles and Prodia Partner to Provide Central Lab Testing Solution in Indonesia

SINGAPORE and JAKARTA, INDONESIA – November 30, 2011 – Quintiles today announced an expanded partnership with Jakarta-based Prodia Clinical Laboratory through its sister company Prodia the CRO, to facilitate rapid testing of  samples from patients in clinical trials in Indonesia.  The partnership will help Quintiles’ biopharmaceutical customers establish the benefits of new medicines in Indonesian patients . Under the agreement, Prodia will provide Quintiles with exclusive access to its central laboratory services for a two-year period. “This agreement demonstrates Quintiles’ commitment to [...]

Read more...

Catabasis begins clinical trial on CAT-1004 drug candidte

Catabasis Pharmaceuticals has commenced the phase 1 clinical trial for its product candidate CAT-1004 to treat patients with type 2 diabetes. CAT-1004, a chemical entity, is a conjugate of the essential omega-3 fatty acid docosahexaenoic acid (DHA) and salicylate. The trial is intended to assess the safety, tolerability and pharmacokinetic profile of CAT-1004 in healthy adult subjects. During the course of the study, nearly 60 subjects will receive a single dose of CAT-1004 or placebo via oral administration. Preclinical studies have demonstrated that [...]

Read more...

Dynavax Heplisav shows superiority over Engerix-B in diabetics

Dynavax Technologies, a biopharmaceutical company, has reported positive results of Phase 3 trial (HBV-16), demonstrating the superiority of Heplisav over Engerix-B in diabetic subset population. Heplisav when given as 2 doses over 4 weeks in modified intent to treat (MITT) analysis of adults with type II diabetes protected a greater proportion of subjects as compared to Engerix-B given as 3 doses over 24 weeks. The MITT subpopulations comprised all diabetic subjects who had received at least one dose of any of [...]

Read more...

Fahrenheit Nutrition launches new multi-vitamin formulas

Fahrenheit Nutrition has introduced two multi-vitamin formulas Fit Men and Fit Women. The products are fortified with essential vitamins, minerals, carotenoids, and phytonutrients which are said to help in maintaining optimum health. In addition, the formulas to contain branch chain amino acids which aid in healing of injured and aging tissues, speed recovery from exercise and protect against catabolism. Fit Women comprises a blend of Resveratrol, Pomegranate, and CoEnzyme Q10 to deliver anti-oxidant and anti-aging benefits.

Read more...